Related references
Note: Only part of the references are listed.Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients
Gemma Caterina Maria Rossi et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2013)
Ocular Surface Disease and Glaucoma: How to Evaluate Impact on Quality of Life
Gemma Caterina Maria Rossi et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Comparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucoma
Stefano Gandolfi et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2012)
Reduced in vivo Ocular Surface Toxicity with Polyquad-Preserved Travoprost versus Benzalkonium-Preserved Travoprost or Latanoprost Ophthalmic Solutions
Hong Liang et al.
OPHTHALMIC RESEARCH (2012)
Comparative In Vitro Toxicology Study of Travoprost Polyquad-preserved, Travoprost BAK-preserved, and Latanoprost BAK-preserved Ophthalmic Solutions on Human Conjunctival Epithelial Cells
Francoise Brignole-Baudouin et al.
CURRENT EYE RESEARCH (2011)
Preservatives in eyedrops: The good, the bad and the ugly
Christophe Baudouin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma
Christophe Baudouin
ACTA OPHTHALMOLOGICA (2008)
Quantitative analysis of conjunctival goblet cells after chronic application of topical drops
Malik Y. Kahook et al.
ADVANCES IN THERAPY (2008)
Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1:: An experimental study
Antoine Labbe et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
European Glaucoma Prevention Study - Author Reply
S Miglior et al.
OPHTHALMOLOGY (2005)
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
PJ Pisella et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Reliability and validity of the ocular surface disease index
RM Schiffman et al.
ARCHIVES OF OPHTHALMOLOGY (2000)
Share Paper
